Siblings' quality of life ‐ by 12 months (reversed FAD, high = good) Reversed FAD. Scale from: 4 to 28. · Siblings of people with severe mental illness
1 finding from 1 review
no estimate extracted
1 study · 9 participants
Low
Siblings' coping (in terms of burden) ‐ by 12 months (FBIS, high = poor) · Siblings of people with severe mental illness
1 finding from 1 review
no estimate extracted
1 study · 9 participants
Low
Mental state · Siblings of people with severe mental illness
1 finding from 1 review
no estimate extracted
1 study · 9 participants
Low
Social functioning · Siblings of people with severe mental illness
1 finding from 1 review
no estimate extracted
1 study · 9 participants
Low
Intervention not reported
Steepness of the cornea (maximal keratometry) (measured using dioptres. A higher dioptre represents steeper cornea and worse outcome) · people with keratoconus
1 finding from 1 review
Intervention not reported
Uncorrected visual acuity (UCVA) (measured using logMAR scale. A score of 0 = good vision, higher score is worse vision) · people with keratoconus
1 finding from 1 review
Mental state: 2. Positive symptoms ‐ average endpoint score PANSS positive subscore · people with severe mental disorders
1 finding from 1 review
Quality of life: 1a. Average endpoint scores on various scales (MSQoL‐54, high = good) ‐ short term · people with severe mental disorders
1 finding from 1 review
Global state Global Assessment Scale (GAS) · people with serious mental illness
1 finding from 1 review
Mental state: psychopathology Total endpoint data, BPRS (higher score = worse, scale from: 0‐126) · people with serious mental illness
1 finding from 1 review
Social functioning · people with serious mental illness
1 finding from 1 review
QoL · people with serious mental illness
1 finding from 1 review
Compliance with medication · people with severe mental disorders
1 finding from 1 review
Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
850 participants
High
BASDAI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
193 participants
Moderate
BASFI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
349 participants
High
BASMI Scale from 0 to 10 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Radiographic progression · patients with axSpA (AS and nr‐axSpA)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BASDAI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
190 participants
Moderate
BASFI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)
1 finding from 1 review
no estimate extracted
356 participants
High